As of January 22, 2025, PolyNovo (PNV.AX) has a market cap of $0.99 billion USD. According to our data, PolyNovo is ranked No.5219 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $0.99 B |
12.25%
|
Dec 31, 2024 | $0.88 B |
23.26%
|
Dec 29, 2023 | $0.72 B |
-18.07%
|
Dec 30, 2022 | $0.88 B |
32.46%
|
Dec 31, 2021 | $0.66 B |
-60.70%
|
Dec 31, 2020 | $1.68 B |
96.95%
|
Dec 31, 2019 | $0.85 B |
231.09%
|
Dec 31, 2018 | $0.26 B |
14.42%
|
Dec 29, 2017 | $0.23 B |
79.31%
|
Dec 30, 2016 | $0.13 B |
0.00%
|
Dec 31, 2015 | $0.13 B |
218.68%
|
Dec 31, 2014 | $39.43 M |
15.19%
|
Dec 31, 2013 | $34.23 M |
79.55%
|
Dec 31, 2012 | $19.06 M |
-21.43%
|
Dec 30, 2011 | $24.26 M |
115.38%
|
Dec 31, 2010 | $11.26 M |
-13.33%
|
Dec 31, 2009 | $13.00 M |
15.38%
|
Dec 31, 2008 | $11.26 M |
-36.59%
|
Dec 31, 2007 | $17.76 M |
-95.03%
|
Dec 29, 2006 | $0.36 B |
79.35%
|
Dec 30, 2005 | $0.20 B |
-64.06%
|
Dec 31, 2004 | $0.55 B |
-83.22%
|
Dec 31, 2003 | $3.31 B |
62.69%
|
Dec 31, 2002 | $2.03 B |
-5.63%
|
Dec 31, 2001 | $2.15 B |
36.54%
|
Dec 29, 2000 | $1.58 B |
-87.62%
|
Dec 31, 1999 | $12.74 B |
252.94%
|
Dec 31, 1998 | $3.61 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Integra LifeSciences
IART
|
$1.94 B |
3.858 M
|
USA
|
Smith & Nephew
SNN
|
$11.01 B |
-0.000 M
|
UK
|
Organogenesis
ORGO
|
$0.44 B |
-0.000 M
|
USA
|
MiMedx Group
MDXG
|
$1.34 B |
-0.000 M
|
USA
|
Avita Medical
RCEL
|
$0.23 B |
0.000 M
|
USA
|
Allogene Therapeutics
ALLO
|
$0.40 B |
0.000 M
|
USA
|
Vericel
VCEL
|
$2.96 B |
24.432 M
|
USA
|
Tanzanian Gold Corporation
TRX
|
$91.66 M |
3.012 M
|
Canada
|
Stryker Corporation
SYK
|
$149.34 B |
-0.003 M
|
USA
|
Zimmer Biomet
ZBH
|
$21.97 B |
-0.000 M
|
USA
|
Medtronic
MDT
|
$112.96 B |
0.003 M
|
Ireland
|
Johnson & Johnson
JNJ
|
$347.78 B |
-0.005 M
|
USA
|
Market Cap | = | PNV.AX Stock Price | * | PNV.AX Shares Outstanding |
= | $1.44 | * | 0.69 B | |
= | $0.99 B |